UCB
The Access & Pricing Strategy Lead will shape integrated payer, pricing, and access strategies to maximize patient access and long-term value across UCB's portfolio. Acting as a strategic partner to Asset Payer Heads, the role involves influencing key development and commercialization decisions while embedding payer perspectives early in the product lifecycle. This position requires leading through influence to align diverse stakeholders around shared priorities and drive decision-ready recommendations.
Headquarters
Brussels, Brussels, Belgium
Company Size
5001-10000 employees
Founded
1928
UCB a global biopharmaceutical leader focuses on creating valuable solutions that improve the lives of people living with neurological and autoimmune conditions
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for UCB.
UCB didn’t post a salary, so this is our estimate from similar listings.
Senior Director, Global Value, Access & Pricing NSCLC Oncology
Revolution Medicines
Director, Global Pricing and Market Access Strategy Lead Immunology
Bristol Myers Squibb
Director, Global Market Access and Pricing Strategy, Cell Therapy
Bristol Myers Squibb
Director, Global Market Access and Pricing Strategy Oncology – Pumitamig
Bristol Myers Squibb
Director Market Access Strategy, Access Optimization Lead
GSK plc
Senior Director, US Market Access Strategy, Povetacicept (POVE)
Vertex